News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
<Research>CICC Elevates INNOVENT BIO's TP to $66; 1Q25 Rev. in Line
INNOVENT BIO (01801.HK)'s 1Q25 product revenue maintained a YoY growth of over 40% to more than RMB2.4 billion, in line with expectations, according to a CICC report.In additio...
Reset
Send
The window will close in 5 seconds
<Research>CICC Elevates INNOVENT BIO's TP to $66; 1Q25 Rev. in Line
Close
Recommend
3
Positive
7
Negative
2
 
SHORT SELL
 
STOCK INFO

INNOVENT BIO (01801.HK)  -0.250 (-0.484%)    Short selling $93.11M; Ratio 9.837%   's 1Q25 product revenue maintained a YoY growth of over 40% to more than RMB2.4 billion, in line with expectations, according to a CICC report.

In addition, the group forecasted that it will present several blockbuster data sets at the 2025 ASCO Annual Meeting, including seven oral presentations.

Related NewsUOB Kay Hian: Buy List Adds BABA-W, INNOVENT BIO, TRIP.COM-S
Given INNOVENT BIO's commitment to continue enriching its portfolio of commercialized products, CICC estimated its 2025 revenue to sustain the strong growth momentum seen in 1Q. The broker kept its 2025-26 net profit forecasts for the group at RMB472 million and RMB1.298 billion, while reiterating the Outperform rating.

CICC also raised its target price for INNOVENT BIO by 12.2% to $66, after taking into account the maturity of the group's IBI363 PoC data and the progress of its ADC pipeline, which are expected to unlock more room for global commercialization.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2025-05-08 16:25.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.